Dara Biosciences
Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees
Dara Biosciences is a small specialty pharmaceutical company based in Raleigh, North Carolina, focused on the development and commercialization of oncology therapies and supportive care. The company holds exclusive U.S. marketing rights to Soltamox, an oral liquid formulation of tamoxifen citrate used in breast cancer treatment and prevention, which serves patients who cannot tolerate conventional tablet formulations. In addition, Dara has secured exclusive U.S. commercial rights for Bionect, an FDA-cleared product indicated for the management of skin irritation in oncology and radiation oncology settings. Operating within the pharmaceutical manufacturing sector, Dara targets clinicians and patients in oncology who require alternative formulations and related supportive care options. By maintaining exclusive U.S. rights to select specialized products for cancer care, the company positions itself to address unmet clinical needs in breast cancer therapy and skin management associated with cancer treatment.